Overview

Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease

Status:
Recruiting

Trial end date:
2020-06-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of Acetyl-L-carnitine in patient with Mild Cognitive Impairment associated with chronic cerebrovascular disease.

Phase:

Phase 4

Details

Lead Sponsor:

Hanmi Pharmaceutical Company Limited

Treatments:

Acetylcarnitine